William McDowall Wells's Net Worth
$23.7 Million
Who is William McDowall Wells?
William McDowall Wells has an estimated net worth of $23.7 Million. This is based on reported shares across multiple companies, which include Valeant Pharmaceuticals International, Inc., and ACADIA PHARMACEUTICALS INC.
SEC CIK
William McDowall Wells's CIK is 0001476860
Past Insider Trading and Trends
2010 was William McDowall Wells's most active year for acquiring shares with 33 total transactions. William McDowall Wells's most active month to acquire stocks was the month of September. 2010 was William McDowall Wells's most active year for disposing of shares, totalling 11 transactions. William McDowall Wells's most active month to dispose stocks was the month of August. 2010 saw William McDowall Wells paying a total of $4,443,184.50 for 864,276 shares, this is the most they've acquired in one year. In 2010 William McDowall Wells cashed out on 1,555,282 shares for a total of $24,040,701.43, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Valeant Pharmaceuticals International, Inc. (BHC) Snapshot price: $6.1229
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -86.74% | -490.46K |
$28.12 | -$14,340,615.43 | 75K |
Dec 6 - Dec 7
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28 - Oct 1
| |||
Form 4
|
—
|
0
|
$18.70 | -$5,256,901.50 | 901.08K |
Nov 9
| |||
Form 4
| +367.39% | 275.54K |
—
|
—
| 350.54K |
Oct 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ACADIA PHARMACEUTICALS INC (ACAD) Snapshot price: $16.07
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
$15.18 | -$160,588.40 |
0
|
Scheduled
|
Nov 21
| ||
Form 4
|
—
|
0
|
$15.26 | -$255,374.48 |
0
|
Scheduled
|
Sep 12
| ||
Form 4
|
—
|
0
|
$14.12 | -$765,600.00 |
0
|
Scheduled
|
Sep 2
| ||
Form 4
|
—
|
0
|
$12.32 | -$321,456.00 |
0
|
Scheduled
|
Jun 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |